Investor Sigma-Tau Takes Another Slice of RegeneRx Pie
This article was originally published in The Pink Sheet Daily
Executive Summary
Cosmeceuticals could bring revenue in 2010, but safer beauty space is no “free lunch,” says troubled biotech’s CEO.